UK's FTSE 100 ends flat as BOJ sparks rate worries, higher on the week
Reuters
Published Jul 28, 2023 08:29
Updated Jul 28, 2023 17:50
By Shubham Batra, Sruthi Shankar and Khushi Singh
(Reuters) - UK's FTSE 100 ended Friday flat after a rally fizzled on worries of higher interest rates sparked by the Bank of Japan's surprise tweak to its yield control policy, while AstraZeneca (NASDAQ:AZN) led gains in the pharmaceutical sector.
The index ended at 7,694.27 points, after clocking its highest level in nine weeks earlier in the session. It scored its third weekly gain in a row.
Pharma stocks jumped 1.8% after AstraZeneca climbed 3.3% as it beat quarterly profit expectations.
Rate-sensitive real estate stocks slipped 1.3% as the UK 10-year gilt yield rose to its highest since July 18 earlier in the session, after the BOJ move was perceived as a shift away from its years of ultra-loose monetary policy.
Investors now await the Bank of England's decision on interest rates next week, with a hike by 25 bps widely anticipated.
The banking index was up 0.9% after major lenders reported results.
Standard Chartered (LON:STAN) Plc rose 4.0% after the Asia-focussed lender upgraded its annual profit forecast and set a new $1 billion share buyback.
Crisis-hit NatWest (LON:NWG) added 2.3% after posting forecast-beating first-half profit as it reels from the abrupt departure of CEO Alison Rose over a public spat with former Brexit party leader Nigel Farage.
"While bad debts remain under control for now, the pressures on UK households are acute and this remains an issue which could flare-up for NatWest and the other banks," shared Russ Mould, investment director at AJ Bell in a note.
British Airways (LON:ICAG) operator IAG was the biggest gainer on the FTSE 100 index, up 6.6% as its quarterly profit beat analyst forecasts by 40%.
The midcap FTSE 250 index, snapped three straight days of gains to fall 0.8%.
Vanquis Banking Group was the top loser on the index, down 29.2%, tumbling to an over three-year low after a half-year loss, compared to a profit last year.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.